Triple

T443408
Position Surface form Disambiguated ID Type / Status
Subject UK Medicines and Healthcare products Regulatory Agency E10163 entity
Predicate alsoKnownAs P39 FINISHED
Object MHRA E10163 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: MHRA | Statement: [UK Medicines and Healthcare products Regulatory Agency, alsoKnownAs, MHRA]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: MHRA
Context triple: [UK Medicines and Healthcare products Regulatory Agency, alsoKnownAs, MHRA]
  • A. UK Medicines and Healthcare products Regulatory Agency chosen
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • D. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • E. Human Tissue Authority
    The Human Tissue Authority is a UK regulatory body responsible for licensing and overseeing the removal, storage, use, and disposal of human bodies, organs, and tissue for purposes such as research, transplantation, and education.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e8465ef481909655c681b01e2986 completed Feb. 28, 2026, 1:06 p.m.
NER Named-entity recognition batch_69a2ef43e8f88190a5d368add11a38c0 completed Feb. 28, 2026, 1:36 p.m.
NED1 Entity disambiguation (via context triple) batch_69a43e7467708190bc80b1d712cba746 completed March 1, 2026, 1:26 p.m.
Created at: Feb. 28, 2026, 1:11 p.m.